l General Information |
Product Name | Iguratimod |
General description | Iguratimod is a small molecule compound with anti-inflammatory and immunomodulatory actions and used for the treatment of rheumatoid arthritis. |
Synonym | T-614; N-[7-(methanesulfonamido)-4-oxo-6-phenoxychromen-3-yl]formamide |
Purity | ≥99.0%(HPLC) | CAS Number | 123663-49-0 |
Formula | C17H14N2O6S | Molecular Weight | 374.36786 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | White to beige Solid |
Solubility(25°C) | DMSO | ≥45mg/ml |
l Storage |
Storage temp. | -20°C |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |
